Latest Stories

P
Screener

2 S&P 500 Stocks with Promising Prospects and 1 We Turn Down

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

Jan 16, 2026
V
Screener

3 Stocks Under $50 We Find Risky

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.

Jan 16, 2026
G
Screener

3 Inflated Stocks We Find Risky

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.

Jan 16, 2026
A
Screener

1 Healthcare Stock to Consider Right Now and 2 We Find Risky

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 21.1% gain over the past six months, beating the S&P 500 by 10.6 percentage points.

Jan 16, 2026
A
Screener

2 Internet Stocks with Solid Fundamentals and 1 Facing Challenges

By breaking down physical barriers, consumer internet businesses are reshaping how people shop, connect, learn, and play. But it’s not all sunshine and rainbows as consumer purchasing power can make or break demand. This unpredictability is weighing on returns as the industry has posted a flat return over the past six months while the S&P 500 was up 10.6%.

Jan 16, 2026
O
Screener

3 Stocks Under $50 We’re Skeptical Of

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

Jan 16, 2026
S
Screener

1 Healthcare Stock Worth Your Attention and 2 We Avoid

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 21.1% over the past six months, topping the S&P 500 by 10.6 percentage points.

Jan 16, 2026
I
Screener

1 Mid-Cap Stock for Long-Term Investors and 2 Facing Challenges

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

Jan 16, 2026
J
Screener

3 Volatile Stocks with Questionable Fundamentals

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

Jan 16, 2026
T
Screener

2 Unpopular Stocks That Should Get More Attention and 1 We Brush Off

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Jan 16, 2026